Nanobiotix
Latest round
- Series C
Last raised
- Aug 2010
Total raised
- $14M
Investors
- 7
About Nanobiotix
Nanobiotix specializes in innovative cancer therapies, focusing on its lead product, NBTXR3, a radio enhancer aimed at improving radiotherapy outcomes for patients with solid tumors while preserving surrounding healthy tissue. Founded in 2003 in Paris, France, Nanobiotix develops advanced cancer treatment solutions.from Invus Financial Advisors and Qatar Holding LLC. CEO Laurent Levy, who is also a founder, leads the company. The firm has completed 9 deals, marking its presence in the oncology therapeutics space. Nanobiotix is dedicated to developing novel cancer therapies, with a particular emphasis on NBTXR3. This first-in-class radio enhancer is designed to amplify the effects of radiotherapy by concentrating radiation in tumor cells while minimizing harm to healthy tissue. The company's innovative approach aims to improve treatment results for patients suffering from various cancers, particularly in head, neck, and lung cancers, and is positioned for global market entry, emphasizing partnerships across North America, Europe, and Asia.
Who invested in Nanobiotix
7 investors across 1 round
See all investors in Nanobiotix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Aug 10, 2010
Amount
$14M
Investors
Questions about Nanobiotix
Who invested in Nanobiotix?
Nanobiotix has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nanobiotix raised?
Nanobiotix has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Nanobiotix last raise money?
Nanobiotix's most recent round on record is a Series C, in Aug 2010.
What does Nanobiotix do?
Nanobiotix specializes in innovative cancer therapies, focusing on its lead product, NBTXR3, a radio enhancer aimed at improving radiotherapy outcomes for patients with solid tumors while preserving surrounding healthy tissue.
Where is Nanobiotix headquartered?
Nanobiotix is headquartered in Paris, France.
Which VCs invest in companies like Nanobiotix?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Nanobiotix's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Nanobiotix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.